These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36245905)

  • 21. Awareness, experience and prevalence of heated tobacco product, IQOS, among young Korean adults.
    Kim J; Yu H; Lee S; Paek YJ
    Tob Control; 2018 Nov; 27(Suppl 1):s74-s77. PubMed ID: 30158210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IQOS point-of-sale marketing strategies in Israel: a pilot study.
    Bar-Zeev Y; Levine H; Rubinstein G; Khateb I; Berg CJ
    Isr J Health Policy Res; 2019 Jan; 8(1):11. PubMed ID: 30642383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corporate communication of the relative health risks of IQOS through a webchat service.
    Braznell S; Branston JR; Gilmore AB
    Tob Control; 2023 Aug; 32(e2):e205-e211. PubMed ID: 35241501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IQOS debut in the USA: Philip Morris International's heated tobacco device introduced in Atlanta, Georgia.
    Churchill V; Weaver SR; Spears CA; Huang J; Massey ZB; Fairman RT; Pechacek TF; Ashley DL; Popova L
    Tob Control; 2020 Dec; 29(e1):e152-e154. PubMed ID: 32024772
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of IQOS introduction on Philip Morris International cigarette sales in Spain: a Logarithmic Mean Divisa Index decomposition approach.
    Golpe AA; Martín-Álvarez JM; Galiano A; Asensio E
    Gac Sanit; 2022; 36(4):293-300. PubMed ID: 35219532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tobacco heated products: a new challenge in tobacco control].
    Peruga A; Rodríguez Lozano F; López MJ; Córdoba García R; Nerín I; Sureda X; Fernández E
    Gac Sanit; 2022; 36(1):57-59. PubMed ID: 33563478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IQOS marketing strategies at point-of-sales: a cross-sectional survey with retailers.
    Bar-Zeev Y; Berg CJ; Khayat A; Romm KF; Wysota CN; Abroms LC; Elbaz D; Levine H
    Tob Control; 2023 Aug; 32(e2):e198-e204. PubMed ID: 35140170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Young Adult Correlates of IQOS Curiosity, Interest, and Likelihood of Use.
    Phan L; Strasser AA; Johnson AC; Villanti AC; Niaura R; Rehberg K; Mays D
    Tob Regul Sci; 2020 Mar; 6(2):81-90. PubMed ID: 34504901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marketing IQOS in a dark market.
    Mathers A; Schwartz R; O'Connor S; Fung M; Diemert L
    Tob Control; 2019 Mar; 28(2):237-238. PubMed ID: 29724866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Point-of-sale marketing of heated tobacco products in Israel: cause for concern.
    Halpern-Felsher B
    Isr J Health Policy Res; 2019 May; 8(1):47. PubMed ID: 31133053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of FDA endorsement and modified risk versus exposure messaging in IQOS ads: a randomised factorial experiment among US and Israeli adults.
    Berg CJ; Duan Z; Wang Y; Thrasher JF; Bar-Zeev Y; Abroms LC; Romm KF; Khayat A; Levine H
    Tob Control; 2024 Mar; 33(e1):e69-e77. PubMed ID: 36428095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving IQOS packaging designs change perceptions of product appeal, uniqueness, quality and safety: a randomised experiment, 2018, USA.
    Lee JGL; Blanchflower TM; O'Brien KF; Averett PE; Cofie LE; Gregory KR
    Tob Control; 2019 Aug; 28(e1):e52-e55. PubMed ID: 31164489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [WHO Framework Convention on Tobacco Control: adherence and establishment in Latin America].
    Portes LH; Machado CV
    Rev Panam Salud Publica; 2015 Nov; 38(5):370-9. PubMed ID: 26837522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The FCTC dilemma on heated tobacco products.
    Gruszczynski L; Melillo M
    Global Health; 2020 Sep; 16(1):81. PubMed ID: 32912239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free-Base and Total Nicotine, Reactive Oxygen Species, and Carbonyl Emissions From IQOS, a Heated Tobacco Product.
    Salman R; Talih S; El-Hage R; Haddad C; Karaoghlanian N; El-Hellani A; Saliba NA; Shihadeh A
    Nicotine Tob Res; 2019 Aug; 21(9):1285-1288. PubMed ID: 30476301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.
    Gentzke AS; Wang TW; Cornelius M; Park-Lee E; Ren C; Sawdey MD; Cullen KA; Loretan C; Jamal A; Homa DM
    MMWR Surveill Summ; 2022 Mar; 71(5):1-29. PubMed ID: 35271557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Ingenious Enemy: Heat-Not-Burn Products.
    Kim SC; Friedman TC
    Tob Use Insights; 2022; 15():1179173X221076419. PubMed ID: 35237081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product (
    Afolalu EF; Langer P; Fischer K; Roulet S; Magnani P
    F1000Res; 2021; 10():504. PubMed ID: 35528952
    [No Abstract]   [Full Text] [Related]  

  • 39. Household Surveys in the General Population and Web-Based Surveys in IQOS Users Registered at the Philip Morris International IQOS User Database: Protocols on the Use of Tobacco- and Nicotine-Containing Products in Germany, Italy, and the United Kingdom (Greater London), 2018-2020.
    Sponsiello-Wang Z; Langer P; Prieto L; Dobrynina M; Skiada D; Camille N; Weitkunat R; Lüdicke F
    JMIR Res Protoc; 2019 May; 8(5):e12061. PubMed ID: 31094340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of mainstream emissions, secondhand emissions and the environmental impact of IQOS waste: a systematic review on IQOS that accounts for data source.
    El-Kaassamani M; Yen M; Talih S; El-Hellani A
    Tob Control; 2022 May; ():. PubMed ID: 35568394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.